Download PDF

1. Company Snapshot

1.a. Company Description

IVF Hartmann Holding AG provides medical consumer goods in Switzerland and internationally.The company offers surgical disposable instruments, blankets, clothing and gloves, disinfection and hygiene products, wound management and hydrotherapy services, incontinence management, and first aid products, as well as various courses.It serves private doctors; outpatient medicine and care; hospitals and clinics; pharmacies and drugstores; nursing homes; and medical and food retailers, as well as industrial customers.


The company was formerly known as IVF and changed its name to IVF Hartmann Holding AG in 1993.The company was founded in 1874 and is headquartered in Neuhausen am Rheinfall, Switzerland.

Show Full description

1.b. Last Insights on VBSN

Have nothing to say about that one ...

1.c. Company Highlights

2. Transcript Summary

Unfortunately this company is not part of our coverage yet. But as part of your subscription plan you can request it by clicking just below and we'll process.

Request Coverage

3. NewsRoom

Card image cap

Calculating The Intrinsic Value Of IVF Hartmann Holding AG (VTX:VBSN)

Oct -16

Source:

Card image cap

European Dividend Stocks To Watch In July 2025

Jul -22

Source:

Card image cap

Returns Are Gaining Momentum At BayWa (ETR:BYW)

Jun -12

Source:

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (4.76%)

6. Segments

Infection Management

Expected Growth: 4.8%

Increasing awareness about hospital-acquired infections, growing demand for infection prevention and control measures, and advancements in medical technology are driving the growth of the Infection Management segment.

Wound Care

Expected Growth: 4.8%

Increasing prevalence of chronic wounds, growing geriatric population, and advancements in wound care technologies drive the demand for innovative wound management solutions, such as those offered by IVF Hartmann Holding AG.

Incontinence Management

Expected Growth: 4.8%

Growing demand for incontinence management solutions, increasing awareness about incontinence, and innovative products from IVF Hartmann Holding AG drive market growth.

Other

Expected Growth: 4.5%

The 'Other' segment's growth is driven by increasing demand for engineering services and trading activities, fueled by industrial automation and digitalization trends, as well as the company's strategic expansion into new markets.

7. Detailed Products

Medical Devices

IVF Hartmann Holding AG offers a range of medical devices for hospitals, clinics, and medical practices, including surgical instruments, implantable devices, and diagnostic equipment.

Orthopedic Implants

The company provides a variety of orthopedic implants, including joint replacements, osteosynthesis systems, and spinal implants.

Surgical Instruments

IVF Hartmann Holding AG offers a comprehensive range of surgical instruments, including forceps, scissors, and retractors.

Diagnostic Equipment

The company provides diagnostic equipment, including ultrasound machines, ECG devices, and patient monitoring systems.

Wound Care Products

IVF Hartmann Holding AG offers a range of wound care products, including dressings, bandages, and surgical sutures.

Infection Prevention Products

The company provides infection prevention products, including disinfectants, sterilization equipment, and personal protective equipment.

8. IVF Hartmann Holding AG's Porter Forces

Forces Ranking

Threat Of Substitutes

The threat of substitutes for IVF Hartmann Holding AG is moderate, as there are alternative products and services available in the market, but they are not highly attractive to customers.

Bargaining Power Of Customers

The bargaining power of customers for IVF Hartmann Holding AG is low, as customers have limited options and the company has a strong brand presence.

Bargaining Power Of Suppliers

The bargaining power of suppliers for IVF Hartmann Holding AG is moderate, as suppliers have some negotiating power, but the company has a diversified supply chain.

Threat Of New Entrants

The threat of new entrants for IVF Hartmann Holding AG is high, as the market is attractive and there are low barriers to entry.

Intensity Of Rivalry

The intensity of rivalry for IVF Hartmann Holding AG is high, as the market is highly competitive and there are many established players.

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 0.88%
Debt Cost 3.95%
Equity Weight 99.12%
Equity Cost 6.35%
WACC 6.33%
Leverage 0.89%

11. Quality Control: IVF Hartmann Holding AG passed 6 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
Synsam

A-Score: 5.8/10

Value: 4.7

Growth: 6.8

Quality: 5.2

Yield: 5.6

Momentum: 8.0

Volatility: 4.7

1-Year Total Return ->

View Full Report
Stock-Card
IVF Hartmann Holding

A-Score: 5.6/10

Value: 4.4

Growth: 5.0

Quality: 7.0

Yield: 5.6

Momentum: 4.0

Volatility: 7.7

1-Year Total Return ->

View Full Report
Stock-Card
Tristel

A-Score: 4.8/10

Value: 2.3

Growth: 6.9

Quality: 8.2

Yield: 5.0

Momentum: 3.5

Volatility: 3.0

1-Year Total Return ->

View Full Report
Stock-Card
SKAN

A-Score: 3.6/10

Value: 0.6

Growth: 7.8

Quality: 5.8

Yield: 0.6

Momentum: 1.0

Volatility: 6.0

1-Year Total Return ->

View Full Report
Stock-Card
Biotage

A-Score: 3.4/10

Value: 1.3

Growth: 6.3

Quality: 7.0

Yield: 1.2

Momentum: 1.0

Volatility: 3.7

1-Year Total Return ->

View Full Report
Stock-Card
Tobii Dynavox

A-Score: 2.6/10

Value: 0.2

Growth: 5.2

Quality: 4.2

Yield: 0.0

Momentum: 4.0

Volatility: 2.0

1-Year Total Return ->

View Full Report

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

136.0$

Current Price

136$

Potential

-0.00%

Expected Cash-Flows